Session: Viral Replication: Positive and Negative Host Co-Factors

Home

Session 57 Poster Abstracts
Viral Replication: Positive and Negative Host Co-Factors
Wednesday, 1:30 - 3:30 pm
Poster Hall


351	APOBEC3G: A Potent Viral DNA Mutator from the Host H Zhang, B Yang, R J Pomerantz, K Chen, S C Arunachalam, C Zhang, and L Gao Thomas Jefferson Univ., Philadelphia, PA, USA*
352	Species-specific Target Specificity of APOBEC3G M Kobayashi, A Takaori-Kondo, K Shindo, A Abudu, A Sasada, and T Uchiyama Kyoto Univ. Sch. of Med., Japan*
353	A Single Amino Acid Change Controls the Ability of HIV-1 Vif to Discriminate Between Human and African Green Monkey APOBEC3G B Doehle¹, H Bogerd^1,2, H Wiegand^1,2, and B Cullen^1,2 ¹Duke Univ., Durham, NC, USA and ²Howard Hughes Med. Inst.*
354	Biophysical and Structural Analysis of HIV-1 Vif and its Cellular Inhibitor APOBEC3G J Auclair, M Somasundaran, and C Schiffer Univ. of Massachusetts Med. Sch., Worcester, USA*
355	The Sequence of Proviruses Resulting from Vif-defective HIV-1 Infection Supports Direct APOBEC3G Deamination of Minus-strand DNA during Reverse Transcription F Bouchonnet, D Lecossier, F Clavel, and A J Hance* INSERM U552, Paris, France
356	Mapping the Restriction Determinants in HIV-1 Capsid and Defining the Role of Cyclophilin A in Restriction T Hatziioannou, S Cowan, and P D Bieniasz Aaron Diamond AIDS Res. Ctr., New York, NY, USA*
357	Natural Resistance of HIV-1 Primary Isolates to Ref1 M Bobardt, A Saphire, and P Gallay* Scripps Res. Inst., La Jolla, CA, USA
358	ARF-1 Independent Attachment of AP Complexes to Endosomal Membranes by HIV-1 Nef Correlates with Virologic Function J Guatelli^1,2, D Hitchin¹, C Noviello², S Coleman², R Madrid³, and S Benichou³ ¹San Diego VA Healthcare System, CA, USA; ²Univ. of California, San Diego, USA; and ³Inst. Cochin, INSERM, Paris, France*
359	Polymorphisms in Cellular Restriction of HIV-1 Infection A Ciuffi¹, G Bleiber¹, M Munoz¹, R Martinez¹, P Meylan¹, S Bonhoeffer², D Trono³, and A Telenti¹ ¹Univ. of Lausanne, Switzerland; ²Univ. of Zurich, Switzerland; and ³Univ. of Geneva, Switzerland*
360	Inhibition of HIV-1 Replication by a Novel Domain of Sam68, the 68-Kilodalton Src-associated Protein In Mitosis J Zhang^1,2, Y Liu^1,2, J Li^1,2, and J J He^1,2 ¹Indiana Univ. Sch. of Med., Indianapolis, USA and ²Walther Cancer Inst., Indianapolis, IN, USA*
361	A DEAD Box Protein Facilitates HIV-1 Replication as a Critical Cellular Co-factor of Rev R Pomerantz¹, J Fang¹, S Kubota¹, B Yan¹, N Zhou¹, H Zhang¹, and R Godbout² ¹Thomas Jefferson Univ., Philadelphia, PA, USA and ²Univ. of Alberta, Canada*
362	INI/hSNF5 Mediates Specific Incorporation of Components of Sin3A-HDAC Complex into HIV-1 Virions M Sorin, K Davies, SWG Cheng, and G V Kalpana Albert Einstein Coll. of Med., Bronx, NY, USA*
363	Changes in the Ratio of P-TEFb Complexes Correlates with a Reduction in HIV Replication S Biglione, S Byers, D Shutt, D Price, and W Maury Univ. of Iowa, Iowa City, USA*
364	Small Heat Shock Proteins as Innate Antiviral Factors Counteracted by HIV-1 Viral Protein R Y Zhao¹, Z Benko¹, D Liang¹, J Hou¹, K Chiu¹, E Agbottah², M Yu¹, S Innis¹, P Reed¹, W Kabat¹, R T Elder¹, P Di Zarzio², L Taricani³, P G Young³, and M Bukrinsky² ¹Northwestern Univ., Chicago, IL, USA; ²George Washington Univ., Washington, DC, USA; and ³Queen's Univ., Kingston, Ontario, Canada*
365	Role of SHP-1 Deregulation in HTLV-1 Leukemogenesis J Cheng, A Kydd, K Noonan, C Xu, A Murakami, and W Marasco Dana-Farber Cancer Inst., Boston, MA, USA*
366	Niemann Pick Type C: an Important Protein during HIV Infection I Carneiro Leao, and J E K Hildreth Johns Hopkins Sch. of Med., Baltimore, MD*
367	alpha-Defensin-1 Inhibits HIV-1 following Entry and Involves PKC Signaling Pathway T L Chang, J Vargas Jr, A Lukay, and M E Klotman* Mount Sinai Sch. of Med., New York, NY, USA